Categories: Health

Amwell to Participate in Upcoming Investor Conference

 | Source: Amwell

BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the TD Cowen 46th Annual Health Care Conference, taking place in Boston on March 3, including a fireside chat at 3:10 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
press@amwell.com

Investors:
Asher Dewhurst
amwell@icrhealthcare.com 

GlobeNews Wire

Recent Posts

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated…

3 hours ago

Basilea awarded additional CARB-X funding of USD6million to support the clinical development of antibiotic BAL2420

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million…

3 hours ago

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population healthScales program…

3 hours ago

World’s First CAR-T Therapy for Solid Tumors Available in China Soon

A New Hope for Patients with Advanced Gastric and Pancreatic CancersSHANGHAI, April 9, 2026 /PRNewswire/…

3 hours ago

Cango Inc. Announces March 2026 Operational Update; Strategically Optimizing Mining Fleet and Improving Production Economics

DALLAS, April 8, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging…

3 hours ago

Rapidise: Powering India’s Next-Generation Electronics Manufacturing Revolution

AHMEDABAD, India and NEW DELHI, April 9, 2026 /PRNewswire/ -- Rapidise, a leading ODM and…

4 hours ago